Medically reviewed by Alan Lucks | MD, Alan Lucks MDPC Private Practice - New York on February 5th, 2026.
Semaglutide (Wegovy) may increase hair loss risk by 52%
Rapid weight loss and nutrient changes could contribute to hair loss
Women appear to be more susceptible to this side effect
Consultation with a healthcare provider is recommended before starting treatment
Weight loss medications like Wegovy have transformed how many approach obesity and weight management. However, recent research has raised important questions about potential side effects, particularly hair loss. Understanding the connection between prescription medications for weight loss and hair health is crucial for patients considering this treatment.
Wegovy, a brand of semaglutide, has gained significant popularity for its effectiveness in weight loss. While the medication offers promising results for weight management, emerging studies suggest potential hair loss as a notable side effect. Researchers are working to understand the mechanisms behind this phenomenon and its implications for patients.
A comprehensive study from the University of British Columbia examined the relationship between semaglutide and hair loss. Researchers compared oral weight loss medication options and found some compelling evidence about potential hair loss risks.
The study analyzed data from 16 million patients, focusing on 1,926 semaglutide users. Results showed a 52% higher risk of hair loss compared to users of alternative weight loss medications. Interestingly, women seemed particularly vulnerable, with more than two times the risk of experiencing hair loss.
Several factors might contribute to hair loss while using Wegovy:
Physiological Stress from Rapid Weight Loss Sudden, significant weight reduction can disrupt the natural hair growth cycle. The impacts of weight loss on overall health can trigger temporary hair shedding.
Nutritional Deficiencies Semaglutide suppresses appetite, which might lead to reduced nutrient intake. Protein deficiencies, in particular, can directly impact hair health and growth.
Hormonal Changes The medication may induce hormonal shifts that potentially increase the likelihood of androgenic alopecia, a common form of hair loss.
While the study suggests women might be more susceptible, more research is needed to confirm gender-specific risks. Patients with pre-existing nutritional challenges or hormonal imbalances may be more likely to experience hair loss.
Medication |
Hair Loss Risk |
Patient Group |
Additional Notes |
|---|---|---|---|
Wegovy (Semaglutide) |
52% higher |
Primarily women |
Rapid weight loss potential |
Contrave |
Baseline risk |
Mixed |
Less aggressive weight loss |
Other GLP-1 Medications |
Varies |
Individual dependent |
Requires further research |
If you're considering online weight loss prescriptions, it's essential to discuss potential side effects with a healthcare provider. Hair loss might be temporary and manageable, but individual experiences can vary.
No, not all patients experience hair loss. Individual responses differ.
Typically, stress-induced hair loss is temporary and resolves within months.
Protein-rich diets and supplements might mitigate some hair loss risks.
Consult your healthcare provider before making any medication changes.
Your doctor can help explore alternative medications for weight loss.
While the potential for hair loss exists, Wegovy remains an effective weight loss solution for many. Each patient's experience is unique, and the benefits may outweigh potential side effects.
Ready to meet your AI doctor? Get started with Doctronic today.
Weight loss medications like Wegovy have transformed how many approach obesity and weight management. However, recent research has raised important questions about potential [...]
Read More
